Rxelite Stock Market Value
| RXEI Stock | USD 0.0001 0.00 0.00% |
| Symbol | RxElite |
RxElite Price To Book Ratio
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of RxElite. If investors know RxElite will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about RxElite listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.03) | Revenue Per Share | Quarterly Revenue Growth 3.321 | Return On Assets | Return On Equity |
The market value of RxElite is measured differently than its book value, which is the value of RxElite that is recorded on the company's balance sheet. Investors also form their own opinion of RxElite's value that differs from its market value or its book value, called intrinsic value, which is RxElite's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because RxElite's market value can be influenced by many factors that don't directly affect RxElite's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between RxElite's value and its price as these two are different measures arrived at by different means. Investors typically determine if RxElite is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, RxElite's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
RxElite 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to RxElite's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of RxElite.
| 01/21/2025 |
| 01/16/2026 |
If you would invest 0.00 in RxElite on January 21, 2025 and sell it all today you would earn a total of 0.00 from holding RxElite or generate 0.0% return on investment in RxElite over 360 days. RxElite, Inc. engages in the development, manufacture, and marketing of generic prescription drug products in specialty ... More
RxElite Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure RxElite's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess RxElite upside and downside potential and time the market with a certain degree of confidence.
RxElite Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for RxElite's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as RxElite's standard deviation. In reality, there are many statistical measures that can use RxElite historical prices to predict the future RxElite's volatility.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of RxElite's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
RxElite Backtested Returns
We have found three technical indicators for RxElite, which you can use to evaluate the volatility of the company. The company holds a Beta of 0.0, which implies not very significant fluctuations relative to the market. the returns on MARKET and RxElite are completely uncorrelated.
Auto-correlation | 1.00 |
Perfect predictability
RxElite has perfect predictability. Overlapping area represents the amount of predictability between RxElite time series from 21st of January 2025 to 20th of July 2025 and 20th of July 2025 to 16th of January 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of RxElite price movement. The serial correlation of 1.0 indicates that 100.0% of current RxElite price fluctuation can be explain by its past prices.
| Correlation Coefficient | 1.0 | |
| Spearman Rank Test | 1.0 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
RxElite lagged returns against current returns
Autocorrelation, which is RxElite stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting RxElite's stock expected returns. We can calculate the autocorrelation of RxElite returns to help us make a trade decision. For example, suppose you find that RxElite has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
RxElite regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If RxElite stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if RxElite stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in RxElite stock over time.
Current vs Lagged Prices |
| Timeline |
RxElite Lagged Returns
When evaluating RxElite's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of RxElite stock have on its future price. RxElite autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, RxElite autocorrelation shows the relationship between RxElite stock current value and its past values and can show if there is a momentum factor associated with investing in RxElite.
Regressed Prices |
| Timeline |
Currently Active Assets on Macroaxis
When determining whether RxElite offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of RxElite's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Rxelite Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Rxelite Stock:Check out RxElite Correlation, RxElite Volatility and RxElite Alpha and Beta module to complement your research on RxElite. For more detail on how to invest in RxElite Stock please use our How to Invest in RxElite guide.You can also try the CEOs Directory module to screen CEOs from public companies around the world.
RxElite technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.